CreditReports.dk
HomeScreen companies

Center for Clinical and Basic Research A/S Financials, key figures and credit report

CVR number: 21142743 Established 1998 Industry: 72 Scientific research and development
Company contact details
Ballerup Byvej 222, 2750 Ballerup tel: 44525400
Net sales 2 133.4 kDKK FY 2025 -46.3% vs 2024
EBIT margin 22.4 % FY 2025 +20.4 pp vs 2024
Net debt 100 832.6 kDKK FY 2025 +2.8% vs 2024
Quick ratio 0.2 FY 2025 -0.1 vs 2024

Income statement (kDKK)

2021
2022
2023
2024
2025
Fiscal period length1212121212
Net sales94 360.6788 097.9716 070.763 975.622 133.37
Other operating income1 453.64111.98
Purchases during the financial year-55 391.94-48 976.23-4 741.13-2 483.92- 216.40
External services-14 440.18-16 118.91-7 444.40-1 031.74-1 551.54
Gross profit25 982.1923 002.833 885.23459.96477.42
Employee benefit expenses-25 430.02-22 069.75- 600.37- 213.82
Other operating expenses-7 991.82- 169.08
Total depreciation-12 992.99- 694.38
EBIT-20 432.64238.703 284.8677.07477.42
Other financial income6 861.486 269.301 403.5210 293.56631.43
Other financial expenses-1 396.82-1 051.48-4 415.28-4 071.74-17 624.11
Net income from associates (fin.)-2 996.03-2 817.2017 114.174 857.045 176.80
Pre-tax profit-17 964.012 639.3117 387.2811 155.92-11 338.47
Income taxes-5 799.8496.15- 530.493 926.76
Net earnings-23 763.862 735.4617 387.2810 625.43-7 411.71

Assets (kDKK)

2021
2022
2023
2024
2025
Intangible assets total
Buildings354.97
Machinery and equipment339.41
Tangible assets total694.38
Holdings in group member companies51 365.6847 671.0263 602.2270 536.7175 713.51
Investments total54 274.2347 671.0263 602.2270 536.7175 713.51
Long term receivables total
Inventories total
Current trade debtors2 586.20862.630.05
Current amounts owed by group member comp.4 227.6914 771.3419 637.2413 218.44
Prepayments and accrued income244.2254.40
Current other receivables3 083.081 226.161 262.65201.2322.66
Current deferred tax assets410.543 926.76
Short term receivables total10 141.1916 860.131 262.7020 303.4217 167.86
Cash and bank deposits10 205.8313 450.509 218.761 827.841 735.53
Cash and cash equivalents10 205.8313 450.509 218.761 827.841 735.53
Balance sheet total (assets)75 315.6377 981.6474 083.6892 667.9794 616.90

Equity and liabilities (kDKK)

2021
2022
2023
2024
2025
Share capital10 000.0010 000.0010 000.0010 000.0010 000.00
Other reserves10 954.007 259.3421 567.2228 501.7133 678.51
Retained earnings-34 823.37-55 692.11-70 617.32-58 087.08-52 638.44
Profit of the financial year-23 763.862 735.4617 387.2810 625.43-7 411.71
Shareholders equity total-37 633.22-35 697.31-21 662.82-8 959.93-16 371.64
Non-current owed to group member26 865.6732 284.79
Non-current liabilities total26 865.6732 284.79
Advances received3 110.192 320.578 233.62
Current trade creditors11.71663.31404.15478.36186.70
Current owed to group member72 708.0491 639.3494 278.5867 655.08102 568.16
Short-term deferred tax liabilities1 239.85751.21941.03
Other non-interest bearing current liabilities9 013.3818 304.531 063.77268.650.06
Current liabilities total86 083.18113 678.9595 746.5069 343.11110 988.54
Balance sheet total (liabilities)75 315.6377 981.6474 083.6892 667.9794 616.90
Page generated